Sign in
What Should Be Chronic: The Animal, the Model, or Both?
Journal article   Open access  Peer reviewed

What Should Be Chronic: The Animal, the Model, or Both?

Gustavo A. Rubio, Sharon J. Elliot and Marilyn K. Glassberg
Stem cells translational medicine, Vol.5(5), pp.703-703
2016-05-01
PMCID: PMC4835255
PMID: 27091588

Abstract

The systematic review of mesenchymal stromal cell (MSC) therapy in pulmonary fibrosis by Srour and Thébaud published in a recent issue of Stem Cells Translational Medicine is critically reviewed; Rubio et al. suggest that bleomycin-induced lung injury in aged mice studied over time is a more clinically applicable model for human idiopathic pulmonary fibrosis.
url
https://stemcellsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.5966/sctm.2015-0325View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.208 Vasculitis & Autoimmune Disorders
1.208.1262 Idiopathic Pulmonary Fibrosis
Web Of Science research areas
Cell & Tissue Engineering
ESI research areas
Molecular Biology & Genetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details